Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02389530 · ClinicalTrials.gov registry record
Use of Fluorescein Dye for the Removal of Brain Tumors
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 91
- Enrollment target
NCT02389530 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 91 participants.
The verdict
NCT02389530 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
Study Summary
Fluorescein is a dye agent that can be injected through an intravenous line. It has been shown to help tell the difference between brain tumor tissue and normal brain tissue when it is used together with a specialized filter on a microscope in the operating room. The investigators plan to study the use of fluorescein in the removal of brain tumors at a low dose.
Interventions
- DRUG Fluorescein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2015-05 |
| Est. Completion | 2018-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02389530
The ClinicalTrials.gov registry entry for NCT02389530 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluorescein is the first listed.
NCT02389530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02389530 about?
NCT02389530 is a clinical study titled "Use of Fluorescein Dye for the Removal of Brain Tumors". Fluorescein is a dye agent that can be injected through an intravenous line. It has been shown to help tell the difference between brain tumor tissue and normal brain tissue when it is used together with a specialized filter on a microscope in the operating room. The investigators plan to study the ...
What is the current status of trial NCT02389530?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2015-05. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02389530?
The interventions under investigation include: Fluorescein (DRUG).
Who is sponsoring clinical trial NCT02389530?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.